Research and Development
Clinical research is critical to the future of the industry and the development of pharmaceutical cannabinoid medicine. MCA’s R&D program is already underway, focusing on medicines that may help people and animals have a better quality of life.

Manufacturing
Our long-term goal is to manufacture cost-effective, superior-quality, cannabinoid medicine for distribution across Australia and around the world. We are committed to the most up-to-date manufacturing techniques that will be housed within our GMP facility.

Cultivation
MCA has approval to develop a state-of-the-art cultivation facility in regional NSW. Our best-practice GACP & GMP cultivation methods will produce high-quality eco-friendly cannabis products. Off-grid renewable resources will help minimise environmental impact.